MedTrace Logo

Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy

NCT06406010 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-08-26

No results posted yet for this study

Summary

The aim of this study is to determine the effect of PENG blockade on postoperative pain after either ropivacaine 5 mg/mL or saline (placebo) in patients undergoing PAO. The hypothesis of this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo (saline).

Conditions

  • Anesthesia, Local

Interventions

DRUG

Ropivacaine 5mg/ml 20ml

administered in a pericapsular nerve group (PENG) block

DRUG

Saline 0.9%

administered in a pericapsular nerve group (PENG) block

Sponsors & Collaborators

  • Matias Vested

    lead OTHER

Principal Investigators

  • Matias Vested, Md, PhD · Rigshospitalet University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-19
Primary Completion
2026-02-01
Completion
2026-03-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06406010 on ClinicalTrials.gov